Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -3.093M
March 31, 2026 -13.75M
December 31, 2025 -3.703M
September 30, 2025 -4.748M
June 30, 2025 -9.766M
March 31, 2025 -8.740M
December 31, 2024 -5.456M
September 30, 2024 -4.015M
June 30, 2024 -3.352M
March 31, 2024 -2.091M
December 31, 2023 -1.652M
September 30, 2023 -1.131M
June 30, 2023 -5.490M
March 31, 2023 -9.958M
December 31, 2022 -6.148M
September 30, 2022 -7.129M
June 30, 2022 -7.966M
Date Value
March 31, 2022 -5.461M
December 31, 2021 -6.163M
September 30, 2021 -5.615M
June 30, 2021 -12.75M
March 31, 2021 -9.406M
December 31, 2020 -3.964M
September 30, 2020 -12.37M
June 30, 2020 -3.926M
March 31, 2020 -8.160M
December 31, 2019 -11.52M
September 30, 2019 -11.14M
June 30, 2019 -10.54M
March 31, 2019 -0.878M
December 31, 2018 -15.82M
September 30, 2018 2.951M
June 30, 2018 -2.959M
March 31, 2018 -2.771M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Numinus Wellness, Inc. -0.1881M
Cocrystal Pharma, Inc. -3.164M
Edesa Biotech, Inc. -5.408M
CNBX Pharmaceuticals, Inc. -0.1542M
Invion Ltd. --

Net Income (Quarterly) Related Metrics